Title: Wilson's Disease Presenting as Parkinsonism
Authors: Dr Sathawane A M, Dr Humaney N R, Dr Kuthe S S
DOI: https://dx.doi.org/10.18535/jmscr/v5i3.75
Abstract
Wilson's disease (WD) is autosomal recessive disease. It has varied presentation so that WD need to consider in any patient with movement disorder under the age of 50 years. The three movement disorders associated with WD are dystonia, in coordination and tremors. We report a case of a young male who presented with pin rolling tremors of right hand since 3 months. After clinical examination and laboratory investigation, diagnosis of WD was confirmed. Patient was treated with zinc acetate and diet modification. Tremors responded to treatment. This case emphasises that tremors can be the main and presenting feature of WD.
Keywords: Wilson's Disease, movement disorder, tremors, pin rolling tremors, zinc acetate.
References
1. Sanjib Sinha, AB Taly. Wilson's Disease. Part 18 Ch.7 In: YP Munjal, SK Sharma, AK Agarwal, P Gupta et al, editors. API Textbook of Medicine Volume 2, 10th ed. Jaypee Brothers Medical Publication, 2015; p.1716-1721
2. George J. Brewer. wilson's Disease. Ch.429 In: Kasper DL ,Hauser SL, Jameson JL, editors. Harrison's Principles of Internal Medicine, 19th ed. New York: McGraw Hill, 2016; p. 2519-2521
3. Roberts EA, Schilsky ML. Diagnosis and Treatment of Wilson Disease: an update hepatomegaly. 2008: 2089-2111
4. Fahn S, Jankovic J, Hallet M. Principles and practice of movement disorder. 2nd ed. New York: Elsevier Saunder;2011. Wilson disease; pp. 507-12
5. Pagon RA, Adam MP, Ardinger HH et al editors. GeneReviews®[Internet] Seattle (WA): university of Washington, Seattle; 1993-2017. 1999 oct 22[updated 2016 July 29]
6. Rukunuzzaman M. Wilson disease in Bangladeshi children: Analysis of 100 cases. Pediatr Gastrornterol Hepatol Nutr. 2015; 18:121-7
7. Kim TJ, Kim IO, Kim WS et al. MR imaging of brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuro radiol. 2006;27:1373-8
8. Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010;1184:173–187
9. Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR. Wilson disease: description of 282 patients evaluated over 3 decades. Medicine (Baltimore) 2007;86(2):112–121
10. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine (Baltimore) 1992;71(3): 139–164
11. Wiebers DO, Hollenhorst RW, Goldstein NP. The ophthalmologic manifestations of Wilson's disease. Mayo Clin Proc 1977;52 (7):409–416
12. Shivakumar R, Thomas SV. Teaching NeuroImages: face of giant panda and her cub: MRI correlates of Wilson disease. Neurology.2009;72:e50
13. Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006;28(3):141–146.
14. Brewer GJ, Askari F, Lorincz MT, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2006;63 (4):521–527.